ArticleThe Kaohsiung journal of medical sciences2025

Comparative Survival Analysis of Anti-Angiogenic Agent Plus Immunochemotherapy in NSCLC Patients After Frontline EGFR-TKI Treatment: A Retrospective Cohort Study.

Yi-Tse Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.